Combined grant to support HIV/AIDS, Tuberculosis & Malaria programs and Health Systems in Afghanistan Afghanistan - Multicomponent - United Nations Development Programme - UNDP Afghanistan.  This program has the following goals: The goal of the NSP IV is to halt new HIV, STI & Hepatitis infections and improve the health and quality of life of people living with and affected by HIV, STIs, and Hepatitis in Afghanistan over the next five years..  To reduce TB deaths by 75% by the end of 2025 compared to 2015.  To ensure that Afghanistan is on track to eliminate malaria by 2030 – contributing towards country development and the Sustainable Development Goals.  To decrease TB incidence rate by 20% by 2024 (to reach 50% reduction in incidence rate compared to 2015) in order to be aligned with End TB Strategy.  To strengthen the health system to reduce mortality and morbidity associated with ATM and RMNCH. The objectives of this program are: To focus strategically on prevention services for HIV and other infections for key populations (PWID, prisoners and other vulnerable populations).  To increase the case notification of all TB cases at least 12% annually until 2023 and maintain full coverage thereafter, and to sustain treatment success rate, at least, 90% by 2025.  Reducing the reported malaria incidence by 73% at the national level compared with 2016.  To increase the coverage and quality of opiod substitution therapy for people who inject drugs by 2023.  To detect and treat at least 80% of estimated MDR-TB cases by 2025.  Interrupting indigenous transmission of malaria in 23 Provinces (Badghis, Baghlan, Farah, Ghor, Hirat, Jawzjan, Kabul, Kunduz, Nimroz, Parwan, Samangan, Balkh, Bamyan, Dykundi, Kapisa, Panjsher, Sar-e-Pul, Takhar, Urozgan, Badakhshan, Faryab, Logar and Zabul) by 2022.  To increase the coverage and quality of antiretroviral therapy services for people living with HIV by 2023.  To detect and treat at least 50% of the estimated latent TB cases as the accumulation by 2025.  Preventing the re-establishment of local malaria transmission due to importation in all areas where it has been eliminated.  To strengthen capacity and systems to generate strategic information on HIV, STIs and Hepatitis through biological and behavior surveillance, surveys and research for evidence-based response to the HIV, STIs and Hepatitis epidemic.  To increase access of women and children to health care services for RMNCAH, HIV, TB and malaria, reduced stigma and discrimination and promotion of health lifestyles in the community and in health facilities in underserved areas.  To improve the enabling environment to address enhanced coordination, human rights, positive legal environment, strengthened community systems, increased domestic funding, reduced stigma and discrimination, to address the needs and rights of key populations affected by HIV, STIs and Hepatitis.  To maintain and improve the quality of the National Laboratory Network.  To improve institutional capacity of Civil Society Organizations and private sector for effective implementation of TB, Malaria and HIV.  To ensure high quality pharmaceuticals and health commodities by strengthening the supply chain, procurement, management, Quality Assurance and regulatory systems.  To improve the data quality of the HMIS and strengthen the utilization of data for decision-making at all levels